About the position
The Director - Epidemiology at Novo Nordisk plays a pivotal role in leading the development and execution of observational research studies that align with the needs identified during the annual Evidence Generation Plan (EGP) process. This position acts as the Primary Investigator (PI) for Real World Evidence (RWE) studies, utilizing data sources from the Novo Nordisk data platform, and also provides support for additional RWE studies conducted with external data sources. The Director is responsible for executing strategic initiatives that extend beyond the EGP, aimed at enhancing the understanding of RWE and embedding data-driven decision-making throughout the US organization. As a champion for RWE within the US organization, the Director will engage with a diverse range of stakeholders across Clinical Data Science and Evidence (CDSE), Clinical, Medical and Regulatory, Market Access, and Public Affairs. Collaboration with global counterparts in Epidemiology, Data Science, and Global Evidence and Pricing Access is also a key aspect of this role. The Director is tasked with delivering impactful epidemiological contributions within the RWE team through proactive stakeholder engagement, ensuring methodological rigor in observational studies, and leveraging advanced analytics to generate evidence as identified through the EGP. The role requires the Director to serve as the epidemiology subject matter expert, leading and managing RWD analyses within assigned therapeutic areas, and taking on the role of PI for assigned studies. This includes running studies independently, setting direction, and delivering key outputs such as protocols, statistical analysis plans (SAP), study reports, and publications. The Director will utilize the NN Real World Data platform and analytic tools, identifying opportunities to enhance their utility based on the organization’s evidence requirements. Additionally, the Director will develop and maintain stakeholder relationships to optimize the use of RWD within Novo Nordisk, championing data-driven decision-making. The role involves knowledge sharing, mentoring junior colleagues, delivering scientific presentations, and communicating study results to various stakeholders. The Director will also assess RWD sources for potential in-licensing and ensure their continued utility in supporting business objectives, while continuously developing their own skills according to a personal development plan.
Responsibilities
- Lead the development and execution of observational research studies in line with the Evidence Generation Plan (EGP).
- Act as Primary Investigator (PI) for Real World Evidence (RWE) studies utilizing internal and external data sources.
- Execute strategic initiatives to support understanding of RWE and data-driven decision making.
- Engage with stakeholders across Clinical Data Science, Medical, Market Access, and Public Affairs.
- Deliver epidemiological contributions with impact within the RWE team.
- Ensure methodological rigor across observational studies executed within the group.
- Utilize advanced analytics to generate evidence as identified through the EGP.
- Develop and maintain stakeholder relationships to optimize RWD utility.
- Supervise and mentor junior colleagues in the RWE team.
- Communicate study results and methodologies to internal stakeholders and the scientific community.
Requirements
- PhD preferred; Master's degree in epidemiology, biostatistics, health services research, or health economics required.
- 8-10 years of experience in leading RWD analytics and development of RWE.
- Keen knowledge and at least 8 years of experience in research using real world data.
- Experience in advanced analytics including AI and machine learning.
- Demonstrated research accomplishments, including publications and presentations.
- Excellent leadership, communication, and critical thinking skills.
- Strong project management skills with the ability to manage multiple projects effectively.
- Strong business acumen and strategic thinking skills.
Nice-to-haves
- Experience in collaborating with global counterparts in Epidemiology and Data Science.
- Familiarity with regulatory strategies and interactions with the FDA.
Benefits
- Flexible work location options.
- Opportunities for professional development and continuous learning.
- Inclusive workplace culture that celebrates diversity.
